Abstract

Preheating of urine improves the specificity of urinary cryptococcal antigen testing using the lateral flow assay.

Highlights

  • Cryptococcosis by Cryptococcus neoformans is a major opportunistic infection in HIV patients, responsible for a high lethality (13%–44%), mainly in resource-limited countries

  • In Brazil, besides cryptococcosis associated with HIV, another public health problem is the endemic occurrence of cryptococcal meningitis by C. gattii in north and northeast regions with a lethality rate of 35%–40% [2]

  • Diagnosis and treatment is an important strategy for preventing clinical disease and reducing the high lethality rate in HIV patients with detectable CrAg

Read more

Summary

Introduction

Cryptococcosis by Cryptococcus neoformans is a major opportunistic infection in HIV patients, responsible for a high lethality (13%–44%), mainly in resource-limited countries. Early diagnosis is the key to decrease the high lethality rate due to cryptococcosis. Previous studies that used a cryptococcal antigen lateral flow assay (CrAg LFA) Immy in serum, plasma, finger stick whole blood, and cerebrospinal fluid (CSF) demonstrated its high sensitivity and specificity for screening cryptococcosis [3,4]. A urine sample is easier to obtain than blood or CSF, becoming a promising methodology for early diagnosis of cryptococcosis, especially in developing countries [3,4]. Considering that the Cryptococcus target molecule glucuronoxylomannan (GXM) is thermostable, we included a heating step before the CrAg LFA Immy test to overcome the false positive results in urine, as shown in previous studies

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call